Adams, Elizabeth J.
Karthaus, Wouter R.
Hoover, Elizabeth
Liu, Deli
Gruet, Antoine
Zhang, Zeda
Cho, Hyunwoo
DiLoreto, Rose
Chhangawala, Sagar
Liu, Yang
Watson, Philip A.
Davicioni, Elai
Sboner, Andrea
Barbieri, Christopher E.
Bose, Rohit
Leslie, Christina S.
Sawyers, Charles L.
Article History
Received: 10 June 2018
Accepted: 22 May 2019
First Online: 26 June 2019
Competing interests
: C.L.S. serves on the board of directors of Novartis, is a co-founder of ORIC Pharm and co-inventor of enzalutamide and apalutamide. He is a science advisor to Agios, Beigene, Blueprint, Column Group, Foghorn, Housey Pharma, Nextech, KSQ, Petra and PMV. He was a co-founder of Seragon, purchased by Genentech/Roche in 2014. The other authors declare no competing interests.